RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC
{{output}}
The era of precision medicine has resulted in the identification of a number of genomic alterations that can be targeted with novel therapies. In lung adenocarcinomas, a histology structure that accounts for nearly 50% of all cases of lung cancer, and a number... ...
